Investing.com -- CorMedix Inc (NASDAQ:CRMD) shares rose 4.5% in premarket trading Monday after the company announced it will acquire substantially all assets of Heron Therapeutics Inc (NASDAQ:HRTX) for approximately $222.6 million. Heron stock surged 45% on the news.
Tipranks Press Release.
This is the newest page. Registered accounts read further back.